fluorodeoxyglucose f18 has been researched along with Hyperlipoproteinemia Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emami, H; Fayad, ZA; Figueroa, A; Hemphill, LC; Hovingh, GK; Kastelein, JJ; Koopman, MG; Lobatto, ME; MacNabb, MH; Mulder, WJ; Schulte, DM; Sjouke, B; Stroes, ES; Tawakol, A; van der Valk, FM; van Wijk, DF; Verberne, HJ | 1 |
| Jiang, L; Jiao, J; Mi, HZ; Wang, LY; Wang, Q; Yang, SW | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
Topics: Aged; Arteries; Atherosclerosis; Blood Component Removal; Case-Control Studies; Cholesterol, LDL; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Hyperlipoproteinemia Type II; Inflammation; Lipoproteins; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Risk Factors; Tomography, X-Ray Computed | 2014 |
Use of (18)F-FDG PET and MPI with (99m)Tc-MIBI in a patient with delayed diagnosis of homozygous familial hypercholesterolemia.
Topics: Adult; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Hyperlipoproteinemia Type II; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiography; Technetium Tc 99m Sestamibi | 2015 |